Ubl J J, Chen S, Stucki J W
Pharmakologisches Institut, Universität Bern, Switzerland.
Biochem J. 1994 Dec 1;304 ( Pt 2)(Pt 2):561-7. doi: 10.1042/bj3040561.
Rat hepatocytes respond to glycogenolytic stimuli acting via phosphoinositide breakdown (e.g. alpha 1-adrenergic agonists, vasopressin) by oscillations of the free intracellular Ca2+ concentration ([Ca2+]i). We have investigated the action of metformin and phenformin, two anti-diabetic drugs of the biguanide type, on phenylephrine-induced [Ca2+]i oscillations. Metformin and phenformin lowered the frequency of the [Ca2+]i oscillations in a concentration-dependent manner with an IC50 of 0.1 mM and 1 microM, respectively. Simultaneous addition of the biguanides and insulin resulted in a further reduction of the frequency. By contrast, agents which increase the cellular cyclic AMP (cAMP) concentration (glucagon, forskolin, N,2'-O-dibutyryl-cAMP) reversed this inhibition. Furthermore, we investigated whether biguanides influenced the agonist-induced Ca2+ influx across the plasma membrane. When hepatocytes were loaded with the acetoxymethyl ester of fura-2 (fura-2/AM), addition of Mn2+ led to a quench of cellular fura-2, measured at the isosbestic excitation wavelength of 360 nm, until a new steady state was reached. Surprisingly, however, this addition of Mn2+ caused a marked increase of the fluorescence ratio simultaneously measured at 340 and 380 nm during the approach of the 360 nm signal to a new steady state. This observation can be understood on the basis of a compartmentalization of fura-2/AM into intracellular stores sensing the [Ca2+] therein. Subsequent application of phenylephrine resulted in a further decline of the fura-2 signal at 360 nm and a concomitant decrease of the fluorescence ratio. This second phase of the Mn2+ quench and the decrease of the fluorescence ratio could be diminished by addition of either 3 mM metformin or 30 microM phenformin. By contrast, when hepatocytes were loaded with fura-2/pentapotassium salt via a patch pipette, only the initial Mn(2+)-induced quench, measured at 360 nm, but no change of the fluorescence ratio, could be observed. The subsequent addition of phenylephrine and biguanides during the on-going quench caused no further changes, except for a fading oscillatory response. After loading hepatocytes with fluo-3 acetoxymethyl ester, the cells were permeabilized with 5 microM digitonin. Addition of inositol-1,4,5-trisphosphate (IP3) caused a rapid decrease of the remaining cellular fluorescence which could be effectively inhibited by 20 micrograms/ml heparin, indicating a release of Ca2+ from intracellular compartments mediated by IP3. This IP3-induced release of Ca2+ from intracellular stores could be diminished by prior addition of metformin and phenformin.(ABSTRACT TRUNCATED AT 400 WORDS)
大鼠肝细胞通过细胞内游离钙离子浓度([Ca2+]i)的振荡对经由磷酸肌醇分解起作用的糖原分解刺激作出反应(例如α1-肾上腺素能激动剂、血管加压素)。我们研究了两种双胍类抗糖尿病药物二甲双胍和苯乙双胍对去氧肾上腺素诱导的[Ca2+]i振荡的作用。二甲双胍和苯乙双胍以浓度依赖方式降低[Ca2+]i振荡的频率,其半数抑制浓度(IC50)分别为0.1 mM和1 μM。同时添加双胍类药物和胰岛素会导致频率进一步降低。相比之下,增加细胞环磷酸腺苷(cAMP)浓度的药物(胰高血糖素、福斯可林、N,2'-O-二丁酰-cAMP)可逆转这种抑制作用。此外,我们研究了双胍类药物是否影响激动剂诱导的钙离子跨质膜内流。当用fura-2的乙酰氧基甲酯(fura-2/AM)加载肝细胞时,添加Mn2+会导致在360 nm等吸收激发波长下测量的细胞fura-2荧光猝灭,直至达到新的稳态。然而,令人惊讶的是,在360 nm信号接近新稳态的过程中,这种Mn2+的添加同时导致在340和380 nm处同时测量的荧光比值显著增加。基于fura-2/AM在感知其中[Ca2+]的细胞内储存区室中的分隔,这一观察结果可以得到解释。随后施加去氧肾上腺素导致360 nm处的fura-2信号进一步下降以及荧光比值随之降低。Mn2+猝灭的第二阶段以及荧光比值的降低可通过添加3 mM二甲双胍或30 μM苯乙双胍而减弱。相比之下,当通过膜片吸管用fura-2/五钾盐加载肝细胞时,仅能观察到在360 nm处测量的最初Mn(2+)诱导的猝灭,而荧光比值没有变化。在持续猝灭过程中随后添加去氧肾上腺素和双胍类药物除了使振荡反应逐渐减弱外未引起进一步变化。在用fluo-3乙酰氧基甲酯加载肝细胞后,用5 μM洋地黄皂苷使细胞通透。添加肌醇-1,4,5-三磷酸(IP3)导致剩余细胞荧光迅速降低,这可被20 μg/ml肝素有效抑制,表明由IP3介导的细胞内区室中Ca2+的释放。预先添加二甲双胍和苯乙双胍可减弱这种由IP3诱导的细胞内储存区室中Ca2+的释放。(摘要截短为400字)